1355.HK HKSE
Biosysen Limited
1W: +0.0%
1M: +35.2%
3M: +35.2%
YTD: +45.2%
1Y: +42.0%
3Y: -7.1%
5Y: -39.7%
HK$0.20 ($0.02)
-0.02 (-9.26%)
Weekly Expected Move ±23.7%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$24M
-31.0% ▼
5Y CAGR: +12.4%
Capital Expenditures
$255K
+60.6% ▲
5Y CAGR: -47.8%
Free Cash Flow
$24M
-30.4% ▼
5Y CAGR: +28.1%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$12M
+5392.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $144K | -$150K | -$16M | -$59M | -$37M |
| Depreciation & Amort. | $21M | $30M | $31M | $29M | $24M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$1M | -$1M | -$8M | $4M | $13M |
| Other Non-Cash Items | $256K | $2M | $3M | $61M | $25M |
| Operating Cash Flow | $20M | $30M | $9M | $35M | $24M |
| — Investing Activities — | |||||
| Capital Expenditures | -$26M | -$16M | -$3M | -$648K | -$255K |
| Acquisitions (Net) | $7M | $18M | -$328K | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$7M | -$18M | $338K | $4K | $5K |
| Investing Cash Flow | -$26M | -$16M | -$3M | -$644K | -$250K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$13M | -$14M | $5M | -$22M | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $28M | -$5M | -$24M | -$13M | -$28M |
| Financing Cash Flow | $15M | -$20M | -$19M | -$35M | -$12M |
| Net Change in Cash | $9M | -$6M | -$12M | -$220K | $12M |
| Cash End of Period | $20M | $14M | $2M | $2M | $14M |
| Free Cash Flow | -$6M | $14M | $6M | $35M | $24M |